1-13 of 13
Jeremy Larsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance

Matthew Ho, Saurabh Zanwar, Francis K. Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A. Gertz, Wilson Gonsalves, Ronald S. Go, Suzanne Hayman, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma Warsame, Amie Fonder, Miriam Hobbs, Yi L. Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar
Journal: Blood
Blood (2022) 140 (18): 1997–2000.
https://doi.org/10.1182/blood.2022017616
Published: 2022
Includes: Supplemental data
Journal Articles

Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma

Shaji K. Kumar, MD, Magdalini Migkou, Manisha Bhutani, MD, Andrew Spencer, Sikander Ailawadhi, Anna Kalff, MBBS (Hons) FRACP FRCPA, Farzana Walcott, Nabendu Pore, Diana Gibson, Fujun Wang, Lily Cheng, Ioannis Kagiampakis, Marna Williams, Krista Kinneer, Yu Jiang, Jeffrey Zonder, Jeremy Larsen, Shreerang Sirdesai, Andrew J. Yee, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-136375
Published: 2020
Journal Articles

A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE ® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)

Simon J Harrison, MBBS MRCP (UK) PhDFRCPath (UK) FRACP, Monique C. Minnema, MD PhD, Hans C. Lee, MD, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Prashant Kapoor, MD, Deepu Madduri, MD, Jeremy Larsen, Sikander Ailawadhi, Jonathan L. Kaufman, MD, Marc S. Raab, MD, Parameswaran Hari, MD MRCP, Shinsuke Iida, MD PhD, Ravi Vij, MBBS, Faith E. Davies, Robin Lesley, PhD, Vijay V. Upreti, PhD, Zhao Yang, PhD, Anjali Sharma, MD, Alex Minella, MD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134063
Published: 2020
Journal Articles

Daratumumab Plus Lenalidomide and Dexamethasone (DRd) Compared to Daratumumab Plus Pomalidomide and Dexamethasone (DPd) in Relapsed Lenalidomide-Exposed or Refractory Multiple Myeloma (MM) Patients: The Mayo Clinic Experience

Muhamad Alhaj Moustafa, MD, Ricardo Parrondo, MD, Mays F Abdulazeez, MBBS, Vivek Roy, MD, Taimur Sher, MD, Victoria R. Alegria, Rahma M Warsame, MD, Jeremy Larsen, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Prashant Kapoor, MD, Rafael Fonseca, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Suzanne R. Hayman, MD, Craig B. Reeder, MD, Arshi Agrawal, Asher A. Chanan-Khan, MD, Sikander Ailawadhi
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-139929
Published: 2020
Journal Articles

Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone for Treatment of Previously Untreated Light Chain Amyloidosis

Eli Muchtar, MD, Morie A Gertz, MD, Betsy Laplant, MS, Francis K. Buadi, MB, CHB, Nelson Leung, MD, Stephanie M. Peterson, P. Leif Bergsagel, MD, Amie Fonder, PA-C, MS, Yi L. Hwa, NP, Miriam A. Hobbs, APRN, CNP, DNP, Dania Kaehlyn Helgeson, Alanna M. Vossen, Wilson I Gonsalves, MD, Martha Q. Lacy, MD, Prashant Kapoor, MD, Mustaqeem A. Siddiqui, MDMBA, Jeremy Larsen, Rahma M Warsame, MD, Suzanne R. Hayman, MD, Ronald S. Go, MD, David Dingli, MD PhD, Taxiarchis Kourelis, MD, Angela Dispenzieri, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 52–53.
https://doi.org/10.1182/blood-2020-138814
Published: 2020
Journal Articles

First Results of Iberdomide (IBER; CC-220) in Combination with Dexamethasone (DEX) and Daratumumab (DARA) or Bortezomib (BORT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Niels W.C.J. van de Donk, MD PhD, Rakesh Popat, Jeremy Larsen, Monique C. Minnema, Sundar Jagannath, MD, Albert Oriol, Jeffrey Zonder, Paul G. Richardson, MD, Paula Rodriguez-Otero, MD PhD, Ashraf Z. Badros, MD, Edward Stadtmauer, Sara Bringhen, MD, Erica Campagnaro, MD, David S. Siegel, MD PhD, Barbara Gamberi, Mercedes Gironella Mesa, Pieter Sonneveld, MD PhD, Tuong Vi Nguyen, Antonia Di Micco, April Sorrell, Min Chen, Michael Amatangelo, Elisabeth Kueenburg, Sagar Lonial, MD FACP
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-137743
Published: 2020
Journal Articles

Preclinical and Translational Support for Clinical Development of Iberdomide in Combination with Proteasome Inhibitors: Mechanism of Synergy in Clinical Trial CC-220-MM-001

Michael Amatangelo, Chad Bjorklund, Jian Kang, Archana Mukhopadhyay, María Dolores Jiménez Nuñez, Lilly Wong, William Pierceall, Sagar Lonial, MD FACP, Niels W.C.J. van de Donk, Rakesh Popat, Sundar Jagannath, MD, Jeffrey Zonder, Monique C. Minnema, Albert Oriol, Jeremy Larsen, Ashraf Z. Badros, MD, Paula Rodriguez-Otero, MD PhD, Pieter Sonneveld, MD PhD, Tuong Vi Nguyen, Kevin Hong, April Sorrell, Anjan Thakurta
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-137710
Published: 2020
Journal Articles

Preclinical and Translational Data Support Development of Iberdomide in Combination with CD38- and SLAMF7-Directed Monoclonal Antibodies: Evidence for Rational Combinations

Michael Amatangelo, Chad Bjorklund, Peilin Ma, Krista Wollerman, William Pierceall, Sagar Lonial, MD FACP, Niels W.C.J. van de Donk, MD PhD, Rakesh Popat, Sundar Jagannath, MD, Jeffrey Zonder, Monique C. Minnema, Albert Oriol, Jeremy Larsen, Ashraf Z. Badros, MD, Paula Rodriguez-Otero, MD PhD, Pieter Sonneveld, MD PhD, Tuong Vi Nguyen, Kevin Hong, April Sorrell, Anjan Thakurta
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-137667
Published: 2020
Journal Articles

Improving the Definition of Response Assessment: Prognostic Value of Minimal Residual Disease Combined with PET/CT at Day 100 Post Autologous Stem Cell Transplantation in Multiple Myeloma

Miguel Gonzalez-Velez, MD, Mariano Arribas, Heidi E. Kosiorek, MS, Richard Butterfield, III, Carlo Guerrero, MD, Luke Mountjoy, DO, Jeremy Larsen, Craig B. Reeder, MD, P. Leif Bergsagel, MD, A. Keith Stewart, MB, ChB, Rafael Fonseca, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-142845
Published: 2020
Journal Articles

Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone in Relapsed Multiple Myeloma

Francis K. Buadi, MB, CHB, Martha Q. Lacy, MD, Betsy Laplant, MS, Eric Wolfe, Morie A. Gertz, MD, Sikander Ailawadhi, MD, Suzanne R. Hayman, MD, Ronald S. Go, MD, Dania Kaehlyn Helgeson, Vivek Roy, MD, Craig B. Reeder, MD, Amie Fonder, PA-C, MS, Yi L. Hwa, APRN, CNP, DNP, Miriam A. Hobbs, APRN, CNP, DNP, P. Leif Bergsagel, MD, Rafael Fonseca, MD, David Dingli, MD PhD, Wilson I Gonsalves, MD, Prashant Kapoor, MD, Asher A. Chanan-Khan, MD, Taxiarchis Kourelis, MD, Jeremy Larsen, Stephen J Russell, MD PhD, John A. Lust, MD PhD, Taimur Sher, MD, Mustaqeem A. Siddiqui, MDMBA, A. Keith Stewart, MB, ChB, Rahma M Warsame, MD, S. Vincent Rajkumar, MD, Robert A. Kyle, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1904.
https://doi.org/10.1182/blood-2019-131478
Published: 2019
Journal Articles

Translational and Clinical Evidence of a Differentiated Profile for the Novel CELMoD, Iberdomide (CC-220)

Sagar Lonial, Michael Amatangelo, Rakesh Popat, Monique C. Minnema, Jeffrey A. Zonder, Jeremy Larsen, Albert Oriol Rocafiguera, Erica L. Campagnaro, MD, Paula Rodriguez Otero, Ashraf Z. Badros, David S. Siegel, Sundar Jagannath, Sara Bringhen, Mercedes Gironella, Martin F. Kaiser, Gordon Cook, Barbara Gamberi, Pieter Sonneveld, Tuong Vi Nguyen, Min S. Chen, Trevor Homan, Chad C. Bjorklund, Maria Wang, William E. Pierceall, Amine Bensmaine, Anjan Thakurta, Teresa Peluso, Niels W. C. J. Van De Donk
Journal: Blood
Blood (2019) 134 (Supplement_1): 3119.
https://doi.org/10.1182/blood-2019-124298
Published: 2019
Journal Articles

Results of a Flow Cytometry Assay Measuring Oxidative Stress Relief As a Predictor of Immunomodulatory Drugs (IMIDs) Sensitivity in Myeloma

Luke Mountjoy, DO, Sinto Chirackal, PhD, Tania Jain, MD, Marlene Girardo, MS, Jeremy Larsen, MD, Rafael Fonseca, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4443.
https://doi.org/10.1182/blood-2018-99-113710
Published: 2018
Journal Articles

Ibrutinib Therapy in Patients with Waldenstrom Macroglobulinemia: Outcomes Outside of Clinical Trial Setting

Jithma Prasad Abeykoon, MD, Saurabh Zanwar, MBBS, Sikander Ailawadhi, Jeremy Larsen, MD, Morie A. Gertz, MD, Wilson I Gonsalves, MD, Francis K. Buadi, MB, CHB, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD, Rebecca L King, MD, David J Inwards, MD, Martha Q. Lacy, MD, Thomas M. Habermann, MD, Angela Dispenzieri, MD, Thomas E. Witzig, MD, Nelson Leung, MD, Miriam Hobbs, CNP, David Dingli, MD PhD, Robert A. Kyle, MD, Stephen M. Ansell, MD, PhD, Prashant Kapoor, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1606.
https://doi.org/10.1182/blood-2018-99-120044
Published: 2018